Freespira® is Revolutionizing Mental Health Care with Groundbreaking 28-Day At-Home Treatment for Panic Disorder and PTSD

Freespira® is a groundbreaking FDA-cleared at-home treatment designed to alleviate symptoms of Panic Disorder and PTSD by addressing respiratory irregularities in just 28 days. With a focus on simplicity and effectiveness, Freespira® offers a drug-free solution that has been proven to significantly reduce or eliminate symptoms, enabling users to regain control of their lives.

Health plans, self-insured employers, and the Veteran’s Administration have embraced Freespira® as a valuable tool for improving quality of life and reducing medical spending. By providing a non-invasive and accessible treatment option, Freespira® supports the appropriate allocation of healthcare resources while prioritizing the well-being of individuals affected by these conditions.

Empowering Well-being Through Comprehensive Solutions

Freespira leads the charge in providing broad relief solutions, presenting the sole FDA-cleared treatment recognized for its remarkable ability to significantly reduce or eliminate symptoms associated with panic attacks and post-traumatic stress disorder (PTSD). By honing in on the root cause of these conditions—breathing irregularities—Freespira offers a ray of hope to those grappling with the debilitating effects of anxiety.

Targeted Relief in Just 28 Days

In a concise 28-day period, Freespira undertakes the task of addressing underlying breathing irregularities, thereby paving the way for substantial symptom alleviation. Through its innovative approach, individuals experiencing panic attacks and PTSD find solace in the promise of a brighter, anxiety-free future.

A Beacon of Hope for Anxiety Sufferers

For individuals burdened by the weight of anxiety conditions, Freespira serves as a beacon of hope, offering a tangible path towards relief and wellness. With its unique focus on addressing breathing irregularities, Freespira stands as a symbol of empowerment and resilience in the face of anxiety's grip.

Empowering Your Members with Effective Solutions

Navigating the challenges of anxiety attacks and traumatic stress symptoms can be daunting for individuals. Freespira revolutionizes accessibility by offering an at-home treatment option for panic disorder and PTSD, eliminating the need for doctor or therapist visits. Its efficacy in addressing common symptoms like chest pains, shortness of breath, and uncomfortable flashbacks highlights its transformative potential in enhancing the quality of life for your plan members.

Realizing Tangible Benefits for Your Healthcare Program

Panic attacks and PTSD exert a significant financial burden on healthcare programs, leading to heightened claims expenditure per patient. Freespira's innovative at-home treatment option not only addresses these conditions effectively but also streamlines the process, eliminating the need for frequent medical consultations. By prioritizing accessibility and affordability, Freespira ensures that plan members receive the care they need without added complexity or expense.

Groundbreaking Clinical Validation

As the sole FDA-cleared, medication-free digital therapeutic proven to alleviate panic attacks and PTSD symptoms, Freespira sets the gold standard in clinical efficacy. With an impressive treatment adherence rate exceeding 70%, Freespira offers a user-friendly solution that aligns with the diverse needs of your plan members.

Facilitating Seamless Integration and Support

Accessing Freespira's transformative treatment is seamless for all plan members, requiring only a brief clinical assessment to get started. Guided implementation, typically spanning six weeks or more, ensures comprehensive support, including referral/training from clinical teams and case managers, alongside targeted multi-channel communications to enhance membership awareness and engagement.

Unlocking a New Era in Mental Health Care

Freespira's groundbreaking approach, coupled with its proven track record of success, heralds a new era in mental health care. By allowing plan members to take control of their well-being and offering a cost-effective, accessible treatment option, Freespira stands at the forefront of transformative healthcare solutions, revolutionizing the landscape of mental health care provision.

Transform Your Life in Just Four Weeks

Imagine a life free from the grip of panic attacks and PTSD symptoms. With Freespira, that dream can become a reality in just 28 days. Say goodbye to medication and endless visits to the doctor or therapist. With Freespira, you can complete your treatment comfortably at home, using only a tablet, sensor, and custom app.

How It Works: Retraining Breathing Patterns with Freespira

Freespira's simple yet effective approach involves two 17-minute sessions each day for 28 days. During these sessions, a sensor tracks your breathing patterns and provides instant feedback. In just one month, you can transform your breathing habits, significantly reducing symptoms of panic attacks and PTSD.

Affordable Relief: Making Treatment Accessible to All

Wondering about the cost? Many individuals, including veterans with VA benefits, have access to Freespira through their health insurance or employer. For others, the one-time investment is seen as a cost-effective alternative to ongoing copays without experiencing real relief. Speak with one of our expert advisors for a risk-free assessment of your options.

Getting Started: Your Path to Healing

Ready to take the first step towards a brighter future? It all begins with a simple questionnaire about your symptoms and health history. This helps us ensure that Freespira is the right fit for you and allows us to authorize your treatment promptly.

Once authorized, Freespira will be shipped directly to your doorstep within a few days. Following that, you'll have a video call with your personal coach to kick off your 28-day journey to wellness.

Joseph Perekupka, CEO, Freespira®

Joe Perekupka is a proven healthcare leader with over 25 years of commercial experience in various leadership and functional roles. He spent the last ten years commercializing novel technologies with startup and small growth companies focused in the neuroscience market. Prior to Freespira, Joe led commercial and operations for a non-invasive neuromodulation startup where he played critical roles in commercial strategy, product development, global partnerships, BD activities and a successful U.S. IPO. He has also served in contributing roles for the Digital Therapeutics Alliance and DTx societies.

Freespira® uses breathing synchronization to normalize CO2 and respiratory rates in a single 28-day treatment course, reducing your symptoms and the need for emergency medical care.